| abstract |
Disclosed is a method for treating, preventing or managing an asbestos-related disease or disorder. Specific embodiments include an immunomodulatory compound or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, inclusion compound or prodrug thereof alone or as a second active agent. And / or administration in combination with chemotherapy, surgery or radiation therapy. Also disclosed are pharmaceutical compositions, unit dosage forms, and kits suitable for use in the methods of the invention. [Selection figure] None |